DK0458588T3 - Behandling af okulær hypertension med en synergistisk kombination til okulær administration - Google Patents

Behandling af okulær hypertension med en synergistisk kombination til okulær administration

Info

Publication number
DK0458588T3
DK0458588T3 DK91304574.6T DK91304574T DK0458588T3 DK 0458588 T3 DK0458588 T3 DK 0458588T3 DK 91304574 T DK91304574 T DK 91304574T DK 0458588 T3 DK0458588 T3 DK 0458588T3
Authority
DK
Denmark
Prior art keywords
ocular
treatment
synergistic combination
hypertension
administration
Prior art date
Application number
DK91304574.6T
Other languages
English (en)
Inventor
Ryuji Ueno
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of DK0458588T3 publication Critical patent/DK0458588T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
DK91304574.6T 1990-05-22 1991-05-21 Behandling af okulær hypertension med en synergistisk kombination til okulær administration DK0458588T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13290990 1990-05-22

Publications (1)

Publication Number Publication Date
DK0458588T3 true DK0458588T3 (da) 1995-03-13

Family

ID=15092362

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91304574.6T DK0458588T3 (da) 1990-05-22 1991-05-21 Behandling af okulær hypertension med en synergistisk kombination til okulær administration

Country Status (8)

Country Link
US (1) US5208256A (da)
EP (1) EP0458588B1 (da)
JP (1) JPH0798751B2 (da)
AT (1) ATE114470T1 (da)
CA (1) CA2042972C (da)
DE (1) DE69105349T2 (da)
DK (1) DK0458588T3 (da)
ES (1) ES2067864T3 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364884A (en) * 1993-01-21 1994-11-15 Baylor College Of Medicine Arginine compounds as ocular hypotensive agents
US6770675B2 (en) 1997-03-17 2004-08-03 Novartis Ag Compositions and methods for reducing ocular hypertension
WO1998050024A1 (en) * 1997-05-09 1998-11-12 The Mount Sinai School Of Medicine Of The City University Of New York 8-iso-prostaglandins for glaucoma therapy
WO2002092098A1 (en) * 2001-05-14 2002-11-21 Sucampo Ag Method for treating ocular hypertension and glaucoma
AR036276A1 (es) * 2001-08-23 2004-08-25 Sucampo Ag Uso de un compuesto 15-ceto-prostaglandina para el tratamiento de hipertension ocular y glaucoma
US20040076678A1 (en) * 2002-08-21 2004-04-22 Sucampo Ag Opthalmic solution
US8580851B2 (en) * 2002-08-21 2013-11-12 Sucampo Ag Ophthalmic solution
AR043161A1 (es) * 2003-02-14 2005-07-20 Sucampo Pharmaceuticals Inc Composicion oftalmica para tratar hipertension ocular y glaucoma
TWI495471B (zh) * 2003-08-12 2015-08-11 R Tech Ueno Ltd 促進毛髮生長之組成物及方法
US20050119262A1 (en) * 2003-08-21 2005-06-02 Pharmacia Corporation Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent
GB0501192D0 (en) * 2005-01-20 2005-03-02 Resolution Chemicals Ltd Stable prostaglandin-containing compositions
JP4648340B2 (ja) * 2006-02-07 2011-03-09 株式会社アールテック・ウエノ １５−ケトプロスタグランジンｅ誘導体の製造法
EP1985298A1 (en) 2007-04-24 2008-10-29 Azad Pharma AG Ophtalmic oil-in-water emulsions containing prostaglandins
US20100087540A1 (en) * 2008-10-07 2010-04-08 R-Tech Ueno, Ltd. Pharmaceutical composition
WO2012139164A1 (en) * 2011-04-12 2012-10-18 Polyactiva Pty Ltd Polymer conjugated prostaglandin analogues
US11696955B2 (en) 2017-03-14 2023-07-11 Polyactiva Pty Ltd Drug-polymer conjugate

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4062964A (en) * 1975-12-03 1977-12-13 Ciba-Geigy Corporation Antifertility-combinations
JPS52154528A (en) * 1976-05-31 1977-12-22 Kaken Pharmaceut Co Ltd Remedy for glaucoma
US4310543A (en) * 1980-10-09 1982-01-12 Hoffmann-La Roche Inc. Prostaglandin compositions
DE3785602T2 (de) * 1986-03-13 1993-09-02 Univ Columbia Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom.
US4822819A (en) * 1986-11-07 1989-04-18 Alcon Laboratories, Inc. Use of trimoprostil and derivatives in glaucoma therapy
US4822820A (en) * 1986-11-24 1989-04-18 Alcon Laboratories, Inc. Use of tri-methyl PG-F2 a and derivatives in glaucoma therapy
DE3850676T2 (de) * 1987-09-18 1994-11-03 Ueno Seiyaku Oyo Kenkyujo Kk Hypotensive okulare Mittel.
DE68928551T2 (de) * 1988-10-01 1998-04-23 Ueno Seiyaku Oyo Kenkyujo Kk Oculare hypotensive Mittel

Also Published As

Publication number Publication date
DE69105349T2 (de) 1995-04-06
JPH0798751B2 (ja) 1995-10-25
DE69105349D1 (de) 1995-01-12
US5208256A (en) 1993-05-04
EP0458588B1 (en) 1994-11-30
CA2042972A1 (en) 1991-11-23
EP0458588A1 (en) 1991-11-27
ATE114470T1 (de) 1994-12-15
CA2042972C (en) 1996-10-15
JPH04253910A (ja) 1992-09-09
ES2067864T3 (es) 1995-04-01

Similar Documents

Publication Publication Date Title
DK0458588T3 (da) Behandling af okulær hypertension med en synergistisk kombination til okulær administration
MY105121A (en) Pharmaceutical composition for systemic transdermal administration.
ATE108657T1 (de) Galanthemin enthaltende pharmazeutische formulierung zur behandlung des alkoholismus.
ATE76747T1 (de) Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
ATE131730T1 (de) Nukleosidanalogen enthaltende antiviren- zubereitungen
DK0459666T3 (da) Lægemidler mod impotens
PT615754E (pt) Formas solidas de administracao oral de libertacao controlada flupertina
ZA892877B (en) Azelastine-containing medicaments with controlled release of the active substance
DK0498144T3 (da) Anvendelse af acetyl-L-carnitin ved terapeutisk behandling af coma
DE68923169D1 (de) Verwendung von fluor enthaltenden Pyridoncarbonsäure-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von HIV infektionen.
ATE38151T1 (de) Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung.
DK516288D0 (da) Stabilisering af terapeutisk aktive proteiner i farmaceutiske praeparater
FI945510A0 (fi) Klavulaanihapon diamiinisuolat
DE69112192D1 (de) Antiherpes-Castanosperminester.
DK0458589T3 (da) Behandling af okulær hypertension med en okulær synergistisk kombination
DK0458587T3 (da) Behandling af okulær hypertension med en synergistisk kombination til ophthalmisk anvendelse
ES2089387T3 (es) Tratamiento de la hipertension ocular con la ayuda de una combinacion sinergica.
EP0351876A3 (en) Composition for potentiating vaccination effect
IT1243358B (it) Composizioni farmaceutiche per la somministrazione orale di irudina
DK0711163T3 (da) Anvendelse af benzydamin i behandlingen af patologiske tilstande forårsaget af TNF
ES2051864T3 (es) Un procedimiento para preparar una composicion farmaceutica con actividad anti-cancer.
DK0560207T3 (da) Præparat til oral anvendelse baseret på ibuprofen